Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Queen's University
SLT therapy is used as an IOP lowering agent in patients with glaucoma. It is unknown whether the timing of a 2-staged approach to the laser therapy will result in better IOP lowering effect.
This study will evaluate the timing (early vs. late completion of SLT therapy) and determined the IOP lowering effect following the interventions.
Arm 1: Early Completion SLT
180 degrees of SLT on Day 1, 180 degrees of SLT on the other 180 degrees on Day 2
Arm 2: Late Completion SLT
180 degrees of SLT on Day 1, 180 degrees of SLT on the other 180 degrees at the 1 month follow up visit.
Primary Outcome: IOP (mmHg).
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
18 years of age
primary open angle glaucoma or pseudoexfoliation glaucoma